Why Kerala's switch to a generic SMA drug has sparked controversy

Kerala's programme to widen access to treatment for spinal muscular atrophy, a rare genetic disorder that weakens muscles, has run into controversy after the state replaced branded Risdiplam with a generic version. Parents of affected children want the branded drug back, a label on a medicine bottle has raised concerns, and the issue has turned political.